Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Bruker stock

BRKR
US1167941087
813534

Price

65.80
Today +/-
-1.50
Today %
-2.49 %
P

Bruker stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Bruker stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Bruker stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Bruker stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Bruker's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Bruker Stock Price History

DateBruker Price
10/3/202465.80 undefined
10/2/202467.46 undefined
10/1/202466.76 undefined
9/30/202469.06 undefined
9/27/202470.67 undefined
9/26/202470.44 undefined
9/25/202467.25 undefined
9/24/202468.32 undefined
9/23/202467.16 undefined
9/20/202467.54 undefined
9/19/202468.26 undefined
9/18/202466.80 undefined
9/17/202465.03 undefined
9/16/202465.28 undefined
9/13/202465.66 undefined
9/12/202464.73 undefined
9/11/202463.99 undefined
9/10/202463.32 undefined
9/9/202463.37 undefined
9/6/202464.01 undefined
9/5/202465.35 undefined

Bruker Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Bruker, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Bruker from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Bruker’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Bruker. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Bruker’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Bruker’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Bruker’s growth potential.

Bruker Revenue, EBIT and net profit per share

DateBruker RevenueBruker EBITBruker Net Income
2028e4.51 B undefined915.96 M undefined694.88 M undefined
2027e4.29 B undefined827.22 M undefined625.39 M undefined
2026e4.03 B undefined752.84 M undefined539.18 M undefined
2025e3.79 B undefined667.42 M undefined470.6 M undefined
2024e3.47 B undefined576.29 M undefined401.12 M undefined
20232.96 B undefined486.7 M undefined427.2 M undefined
20222.53 B undefined460.1 M undefined296.6 M undefined
20212.42 B undefined426.5 M undefined277.1 M undefined
20201.99 B undefined267.3 M undefined157.8 M undefined
20192.07 B undefined305.3 M undefined197.2 M undefined
20181.9 B undefined277.4 M undefined179.7 M undefined
20171.77 B undefined239 M undefined78.6 M undefined
20161.61 B undefined207.6 M undefined153.6 M undefined
20151.62 B undefined160.1 M undefined101.6 M undefined
20141.81 B undefined134.9 M undefined56.7 M undefined
20131.84 B undefined170.7 M undefined80.1 M undefined
20121.79 B undefined182.2 M undefined77.5 M undefined
20111.65 B undefined164.2 M undefined92.3 M undefined
20101.3 B undefined161.5 M undefined95.4 M undefined
20091.11 B undefined137.1 M undefined81.2 M undefined
20081.11 B undefined116.7 M undefined64.9 M undefined
20071.03 B undefined145.1 M undefined98.9 M undefined
2006851.4 M undefined111.9 M undefined74.4 M undefined
2005372.3 M undefined22.4 M undefined9.7 M undefined
2004357 M undefined6.6 M undefined-3.9 M undefined

Bruker Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e
0.140.180.220.260.360.370.851.031.111.111.31.651.791.841.811.621.611.771.92.071.992.422.532.963.473.794.034.294.51
-21.5325.7118.1837.314.20128.7621.277.270.6317.0626.618.482.68-1.69-10.23-0.749.567.379.34-4.1021.644.6817.1517.079.286.366.455.01
45.1445.7145.9140.7742.0244.6247.0046.0345.6246.4146.3245.5546.2943.7742.2043.6246.2446.2347.4948.0247.2650.0251.6251.15-----
0.070.080.10.110.150.170.40.480.510.520.60.750.830.810.760.710.750.820.910.941.211.311.5200000
3470622111145116137161164182170134160207239277305267426460486576667752827915
2.082.293.18-1.685.9113.0414.0510.4812.3012.359.9310.169.247.419.8612.8513.5414.6214.7213.4417.6318.1816.4016.6017.5918.6519.2620.30
2-3-6-17-3974986481959277805610115378179197157277296427401470539625694
--250.00100.00183.33-82.35-400.00722.2232.43-34.6926.5617.28-3.16-16.303.90-30.0080.3651.49-49.02129.4910.06-20.3076.436.8644.26-6.0917.2114.6815.9611.04
-----------------------------
-----------------------------
71.970.477.581.399.8101.1160.1164.3165.6164.9165.7166.9167.4168.5169.5169.1162.2159.1157.2156.6154.6152.9149.4147.200000
-----------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Bruker Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Bruker is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                           
0.080.030.030.060.050.330.170.210.230.250.310.440.50.470.50.440.320.680.731.170.650.49
4854.767.367.979.6185.2171.9184.1232.9282.8289.3307.6293.2234.7243.9319.3357.2362.2335.3416.9472.7492
0006.5900000000000000000
101.8110.1107.7117.7134.5446.4425.1422.8511576.2611.5589.8477.4422440.4486.2509.6577.2692.3710.1800.1968.3
21.960.563.760.619.569.757.559.876.889.198.395.898.2106.591.3114.1115.1172165.6176.6194.9215.6
0.260.250.270.320.291.030.820.871.051.191.311.431.371.231.281.361.31.81.922.472.112.16
73.281.48585.390.3207.6221.3223.4233.7249283.6299.5249.9231.1239.1266.5270.6371.7462.9466538.2691.4
0000000000000000000000
0000000000000000000000
3.312.61.41.55.66.264.9136.1136.4117105.683.874.769.782.4218.7233.2229.1211.8270.9330.5
0010.717.539.840.846.447.598.3100.2115.9127.4127.8130.6130.6169.8275.7293320.4339.5457.6582.6
96.43.142.722.421.922.730.630.830.223.93762.193.17159.377.3111.6160.9231.9481.2
0.090.10.10.110.140.280.30.30.50.520.550.560.50.50.530.590.820.981.121.181.52.09
0.340.350.370.420.431.311.121.171.551.711.861.991.861.731.811.952.132.773.053.653.614.25
                                           
0.80.90.9111.61.61.61.61.71.71.71.71.71.71.71.71.71.71.71.71.7
180.6201.8213.9217.7149.5202.308.421.73648.363.581.1102.1124.7155.9176.9199.7216.3237.8256.3282.9
0-0.01-0.02-00.020.280.170.250.350.440.520.60.660.760.890.941.11.271.411.661.932.32
2.716.524.711.723.5148.5137.8153.5152.4143.6137.8182.428.2-44.2-75.92717-25.53.7-8.214.86
000000000-1.1000000000000
0.190.20.220.230.190.640.310.420.520.620.710.850.770.820.941.131.31.451.631.892.22.61
22.424.925.723.42952.343.349.86472.369.674.87672.186.190.8104.5118.4134.6147.4178.4202.7
00000161.2117.4117.7134.7147.1164.9172.9148.3149.6136.3160.7164.4181.4186.10195.1239
5665.173.3114.9144.3312318351418.4452.7446400.2357.6332.2282.2273311.9345.3469678.7522.1639.2
11.816.410.27.319.413.222.70.1185.50000000000000
6.62.222.22.522.418.321.928.983.71.30.70.80.620.1018.50.52.2112.418.7121.2
0.10.110.110.150.20.560.520.540.830.760.680.650.580.550.520.520.60.650.790.940.911.2
0.020.030.030.030.020.010.180.120.090.220.340.350.350.270.390.420.320.810.841.221.21.16
0000002125.218.823.812.122.617.89.510.124.351.148.843.14662.367.7
15.913.515.220.223.5105.580.172.185.586.6116.9112.6138.4167.9188.9250.6227.9326.1397.4358.9302.9406.5
0.030.040.040.050.050.110.280.210.190.330.460.490.510.440.590.690.61.191.281.631.571.63
0.130.150.150.190.240.680.80.751.021.091.151.141.0911.121.221.21.832.072.572.482.84
0.320.350.370.420.431.311.121.171.551.711.851.981.861.812.052.342.53.283.74.464.685.45
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Bruker provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Bruker's financial health and stability.

Assets

Bruker's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Bruker must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Bruker after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Bruker's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (k)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
2-6-17-3974996581969478815910415480181198161280298428
861011102627292936525961595354636475808988114
-1-230-15-1-1-2-3-4-117-9-29-2228-15-5-22-5-14-24
-26-20-5-528-20-20-159-6-93-58-46-3946-88-40-42-7469-125-144-87
31223202333740477347526242336229596173-57
111213310646101212121215111628192433
63118265513854386979845556725360614314514796
-13-10-65498510710614915687133145114229130154239213332282274350
-20-28-5-10-4-25-26-47-16-31-61-72-50-33-34-37-43-49-73-97-92-129-106
-1710-40-4-12-5-32-49-18-299-68-93-60-201-102-21-30-123-158-192-192-251-326
339-355-720-5-1-1-267-7-20-9-168-681513-74-85-95-100-122-219
00000000000000000000000
-10142-8-11-3-17173-84163133170-881453-93467-8489-110-21
75501401193163487-79-148-1329-131-119-146-260-142
6419-86-11-105-82-233-84168334266-168-27-159-112300-161318-415-193
00-10,00000-103,000-84,000-410,0000-1,000-1,000-3,0000001,000-4,000-3,000-10,000-8,0000-14,0000
000000000000000-25-25-25-25-24-24-29-29
3320-521021021-16640231564128-119-5275-17-23553386-423-157
-33.6-39.5-11.6-4.444.960.781.459.5133.5124.226.160.394.780.519593.7110.7190.5140.4235190.4145.2243.2
00000000000000000000000

Bruker stock margins

The Bruker margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Bruker. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Bruker.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Bruker's sales revenue. A higher gross margin percentage indicates that the Bruker retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Bruker's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Bruker's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Bruker's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Bruker. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Bruker's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Bruker Margin History

Bruker Gross marginBruker Profit marginBruker EBIT marginBruker Profit margin
2028e51.17 %20.32 %15.41 %
2027e51.17 %19.27 %14.57 %
2026e51.17 %18.67 %13.37 %
2025e51.17 %17.6 %12.41 %
2024e51.17 %16.61 %11.56 %
202351.17 %16.42 %14.41 %
202251.63 %18.18 %11.72 %
202150.03 %17.64 %11.46 %
202047.29 %13.45 %7.94 %
201948.02 %14.73 %9.51 %
201847.48 %14.63 %9.48 %
201746.21 %13.53 %4.45 %
201646.25 %12.88 %9.53 %
201543.64 %9.86 %6.26 %
201442.2 %7.46 %3.13 %
201343.78 %9.28 %4.35 %
201246.3 %10.17 %4.33 %
201145.56 %9.94 %5.59 %
201046.29 %12.38 %7.31 %
200946.43 %12.3 %7.29 %
200845.61 %10.54 %5.86 %
200746.07 %14.05 %9.58 %
200647.04 %13.14 %8.74 %
200544.59 %6.02 %2.61 %
200442.27 %1.85 %-1.09 %

Bruker Stock Sales Revenue, EBIT, Earnings per Share

The Bruker earnings per share therefore indicates how much revenue Bruker has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Bruker earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Bruker's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Bruker’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Bruker's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Bruker Revenue, EBIT and net profit per share

DateBruker Sales per ShareBruker EBIT per shareBruker Earnings per Share
2028e29.78 undefined0 undefined4.59 undefined
2027e28.36 undefined0 undefined4.13 undefined
2026e26.64 undefined0 undefined3.56 undefined
2025e25.05 undefined0 undefined3.11 undefined
2024e22.92 undefined0 undefined2.65 undefined
202320.14 undefined3.31 undefined2.9 undefined
202216.94 undefined3.08 undefined1.99 undefined
202115.81 undefined2.79 undefined1.81 undefined
202012.86 undefined1.73 undefined1.02 undefined
201913.23 undefined1.95 undefined1.26 undefined
201812.06 undefined1.76 undefined1.14 undefined
201711.1 undefined1.5 undefined0.49 undefined
20169.93 undefined1.28 undefined0.95 undefined
20159.6 undefined0.95 undefined0.6 undefined
201410.67 undefined0.8 undefined0.33 undefined
201310.92 undefined1.01 undefined0.48 undefined
201210.7 undefined1.09 undefined0.46 undefined
20119.9 undefined0.98 undefined0.55 undefined
20107.88 undefined0.97 undefined0.58 undefined
20096.76 undefined0.83 undefined0.49 undefined
20086.69 undefined0.7 undefined0.39 undefined
20076.28 undefined0.88 undefined0.6 undefined
20065.32 undefined0.7 undefined0.46 undefined
20053.68 undefined0.22 undefined0.1 undefined
20043.58 undefined0.07 undefined-0.04 undefined

Bruker business model

The Bruker Corporation is a leading manufacturer of scientific instruments and solutions for the life science, pharmaceutical, biotech, forensic, clinical, and chemical industries. The company was founded in 1960 and is headquartered in Billerica, Massachusetts, USA. Bruker is divided into four main business segments: Scientific Instruments, Energy and Supercon Technologies, Optics, and Advanced Systems. The products and solutions are used in research, development, and industrial processes in more than 100 countries worldwide. The Scientific Instruments segment offers a wide range of analytical instruments, including X-ray spectroscopy, mass spectrometry, infrared spectroscopy, NMR, microtomography, and electron microscopy, as well as automated laboratory equipment. These instruments are used to investigate and analyze materials, processes, and organisms to gain insights into molecular, atomic, and microscopic connections. The Energy and Supercon Technologies segment is involved in the research and development of innovative technologies and products that contribute to energy generation, transmission, and storage. This includes superconducting magnets, magnetic resonance imaging systems, and NMR spectrometers combined with high-field magnet systems. In the Optics segment, Bruker develops and manufactures optical technologies and components for applications in the life science, microelectronics, semiconductor, military, and aerospace industries. The products range from high-performance microscopes and spectrometers to laser interferometry systems. In the Advanced Systems segment, Bruker offers automated system solutions for semiconductor manufacturing, microelectronics, food technology, and clinical laboratories, which increase production efficiency, save resources, and improve product quality. The systems can range from handling robots to process control systems and quality inspection solutions. Bruker's products have a central role in research, development, and manufacturing of drugs and medical devices, as well as in material and environmental analysis and other application areas. The company's focus is on the research and development of innovative technologies and products for the future. In recent years, Bruker has also invested in the field of artificial intelligence (AI) and machine learning algorithms to further improve the analysis and data evaluation of experimental results. Thanks to these advancements, Bruker is able to be a pioneer in the research and development of cutting-edge applications and solutions. Overall, Bruker is an important player in the analytical instrument industry with a wide range of products that are used worldwide in a large number of application areas. The company provides innovative solutions for a wide range of scientific and industrial needs and drives continuous progress in various industries. Bruker is one of the most popular companies on Eulerpool.com.

Bruker Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Bruker historical P/E ratio, EBIT multiple, and P/S ratio

Bruker shares outstanding

The number of shares was Bruker in 2023 — This indicates how many shares 147.2 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Bruker earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Bruker's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Bruker’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Bruker's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Bruker dividend history and estimates

In 2023, Bruker paid a dividend amounting to 0.2 USD. Dividend means that Bruker distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Bruker provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Bruker’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Bruker's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Bruker Dividend History

DateBruker Dividend
2028e0.25 undefined
2027e0.25 undefined
2026e0.25 undefined
2025e0.25 undefined
2024e0.25 undefined
20230.2 undefined
20220.2 undefined
20210.16 undefined
20200.16 undefined
20190.16 undefined
20180.16 undefined
20170.16 undefined
20160.16 undefined

Bruker dividend payout ratio

In 2023, Bruker had a payout ratio of 11.53%. The payout ratio indicates the percentage of the company's profits that Bruker distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Bruker represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Bruker could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Bruker's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Bruker Payout Ratio History

DateBruker Payout ratio
2028e10.6 %
2027e10.48 %
2026e10.75 %
2025e10.57 %
2024e10.14 %
202311.53 %
202210.05 %
20218.84 %
202015.69 %
201912.7 %
201814.04 %
201732.65 %
201616.84 %
201511.53 %
201411.53 %
201311.53 %
201211.53 %
201111.53 %
201011.53 %
200911.53 %
200811.53 %
200711.53 %
200611.53 %
200511.53 %
200411.53 %
Unfortunately, there are currently no price targets and forecasts available for Bruker.

Bruker latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20240.53 0.52  (-2.59 %)2024 Q2
3/31/20240.47 0.53  (12.05 %)2024 Q1
12/31/20230.69 0.8  (15.12 %)2023 Q4
9/30/20230.64 0.74  (14.82 %)2023 Q3
6/30/20230.49 0.5  (1.03 %)2023 Q2
3/31/20230.56 0.64  (14.35 %)2023 Q1
12/31/20220.74 0.74  (0.43 %)2022 Q4
9/30/20220.56 0.66  (18.36 %)2022 Q3
6/30/20220.46 0.45  (-2.02 %)2022 Q2
3/31/20220.43 0.49  (14.54 %)2022 Q1
1
2
3
4
5
...
10

Eulerpool ESG Scorecard© for the Bruker stock

Eulerpool World ESG Rating (EESG©)

68/ 100

🌱 Environment

87

👫 Social

62

🏛️ Governance

56

Environment

Scope 1 - Direct Emissions
3,621
Scope 2 - Indirect emissions from purchased energy
10,426
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
14,047
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
❌
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
✅
Environmentally friendly packaging
❌
Hazardous substances
✅
Fuel consumption and efficiency
❌
Water consumption and efficiency
✅

Social

Percentage of female employees26
Percentage of women in management—
Percentage of Asian employees15
Share of Asian management—
Percentage of Hispanic/Latino employees10
Hispano/Latino Management share—
Percentage of Black employees4
Black Management Share—
Percentage of white employees67
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept✅
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting✅
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Bruker shareholders

%
Name
Stocks
Change
Date
8.71414 % T. Rowe Price Investment Management, Inc.13,192,34429,57012/31/2023
6.52343 % The Vanguard Group, Inc.9,875,825-434,35812/31/2023
6.26228 % Pallas Capital Advisors LLC9,480,4711,055,1143/31/2024
5.81296 % BlackRock Institutional Trust Company, N.A.8,800,247-312,71112/31/2023
5.72394 % Fidelity Management & Research Company LLC8,665,479-260,13512/31/2023
5.20282 % MFS Investment Management7,876,543260,31412/31/2023
4.96451 % Laukien (Joerg C)7,515,76904/1/2024
26.56992 % Laukien (Frank H)40,224,207482,1774/1/2024
2.20893 % RTW Investments L.P.3,344,095-37,60812/31/2023
2.08558 % State Street Global Advisors (US)3,157,36159,04212/31/2023
1
2
3
4
5
...
10

Bruker Executives and Management Board

Dr. Frank Laukien63
Bruker Chairman of the Board, President, Chief Executive Officer (since 1991)
Compensation 5.06 M
Dr. Mark Munch61
Bruker Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
Compensation 2.5 M
Mr. Gerald Herman65
Bruker Chief Financial Officer, Executive Vice President
Compensation 1.9 M
Mr. Juergen Srega68
Bruker President of Bruker CALID Group and Bruker Daltonics Division
Compensation 1.28 M
Dr. Falko Busse56
Bruker President, Bruker BioSpin Group
Compensation 1.15 M
1
2
3

Bruker Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Meridian Bioscience Stock
Meridian Bioscience
SupplierCustomer0,950,91-0,25-0,78-0,740,09
PerkinElmer Stock
PerkinElmer
SupplierCustomer0,940,960,940,840,500,85
Allegheny Technologies Stock
Allegheny Technologies
SupplierCustomer0,840,32-0,63-0,87-0,800,56
Canon Marketing Japan Stock
Canon Marketing Japan
SupplierCustomer0,72-0,32-0,48-0,62-0,090,70
Scientech Stock
Scientech
SupplierCustomer0,660,880,77-0,33-0,560,44
Fujikura Stock
Fujikura
SupplierCustomer0,620,190,50-0,180,87
Oxford Instruments Stock
Oxford Instruments
SupplierCustomer0,46-0,68-0,230,550,710,92
Hangzhou Gaoxin A Stock
Hangzhou Gaoxin A
SupplierCustomer0,460,680,70-0,46-0,50-0,60
DKSH Holding Stock
DKSH Holding
SupplierCustomer0,41-0,36-0,61-0,68-0,600,71
bioMerieux Stock
bioMerieux
SupplierCustomer0,370,800,480,910,59-0,60
1
2

Most common questions regarding Bruker

What values and corporate philosophy does Bruker represent?

Bruker Corp represents values of innovation, collaboration, and excellence. As a leading provider of scientific instruments and solutions, Bruker Corp is committed to delivering cutting-edge technology to enable advancements in research and analysis. Their corporate philosophy revolves around customer-centricity, striving to understand the unique needs of their clients and providing tailored solutions to meet their requirements. With a focus on quality, Bruker Corp emphasizes continuous improvement and rigorous standards in their products and services. By fostering strategic partnerships and fostering a culture of continuous learning, Bruker Corp aims to drive scientific discovery and empower researchers worldwide.

In which countries and regions is Bruker primarily present?

Bruker Corp is primarily present in various countries and regions around the world. These include the United States, Germany, China, Japan, India, France, the United Kingdom, and many others. With a global presence, Bruker Corp caters to a wide range of customers and markets its innovative analytical instruments and solutions internationally.

What significant milestones has the company Bruker achieved?

Bruker Corp has achieved several significant milestones throughout its history. One notable accomplishment is the company's successful expansion into various analytical and diagnostic technologies. Bruker Corp has also made significant advancements in the field of scientific research, particularly in the areas of life sciences, materials research, and industrial applications. Moreover, the company has consistently strived to innovate and develop cutting-edge solutions that cater to its customers' diverse needs. Bruker Corp's commitment to excellence and its focus on delivering high-quality products and services have contributed to its industry-leading position and continued growth.

What is the history and background of the company Bruker?

Bruker Corp is a renowned scientific instruments and solutions provider, headquartered in Billerica, Massachusetts. Founded in 1960 by Dr. Günther Laukien, the company has a rich history of innovative developments in analytical and diagnostic equipment. Bruker Corp initially focused on the design and manufacture of NMR spectroscopy systems and quickly gained recognition for its cutting-edge technology. Over the years, the company expanded its product portfolio to include technologies for life sciences, materials research, clinical research, and more. Bruker Corp has a global presence, serving a diverse range of industries, including pharmaceuticals, biotechnology, academia, and government institutions. It continues to be a leading player in the scientific instrumentation field with a commitment to advancing research and enabling scientific discovery.

Who are the main competitors of Bruker in the market?

The main competitors of Bruker Corp in the market include Agilent Technologies, Thermo Fisher Scientific, and Shimadzu Corporation.

In which industries is Bruker primarily active?

Bruker Corp is primarily active in the life sciences and analytical research industries.

What is the business model of Bruker?

Bruker Corp is a leading scientific instruments and solutions provider. Their business model centers around developing and manufacturing analytical and diagnostic technological tools for various industries. The company offers a wide range of high-performance products such as mass spectrometers, magnetic resonance instruments, and surface analytical systems. Bruker Corp caters to diverse sectors including life sciences, pharmaceuticals, materials research, and industrial applications. With a focus on innovation and customer-centricity, Bruker Corp continuously strives to enhance its product portfolio and provide advanced scientific solutions to meet the evolving needs of its global clientele.

What is the P/E ratio of Bruker 2024?

The Bruker P/E ratio is 24.15.

What is the P/S ratio of Bruker 2024?

The Bruker P/S ratio is 2.79.

What is the AlleAktien quality score of Bruker?

The AlleAktien quality score for Bruker is 9/10.

What is the revenue of Bruker 2024?

The expected Bruker revenue is 3.47 B USD.

How high is the profit of Bruker 2024?

The expected Bruker profit is 401.12 M USD.

What is the business model of Bruker

The Bruker Corporation is a company for scientific instruments and solutions, focusing on analytical and diagnostic instruments for applications in biology, chemistry, and physics. The company was founded in 1960 and has its headquarters in Billerica, Massachusetts. Bruker's business activities are divided into four different segments: 1. Scientific Instruments This segment is the main revenue driver for Bruker and focuses on the development, manufacturing, and marketing of scientific instruments and solutions for research, diagnostic, and analytical applications in a variety of industries. For example, analytical instruments for the pharmaceutical industry, cosmetics industry, food industry, environmental monitoring, and materials science are offered here. The product range includes spectroscopy systems, mass spectrometry, NMR spectroscopy, X-ray analysis, optical emission spectroscopy, and microscopy. 2. Energy & Supercon Technologies This segment offers a wide range of products and solutions for the energy industry as well as for research and development in the field of superconductivity. Bruker is a major provider of analysis, measurement, control, and monitoring systems for the power and gas supply infrastructure, as well as for the development of materials for energy generation and transmission. The solutions offered include spectroscopy systems, analytical sensors, magnetic resonance imaging systems, and superconducting magnets. 3. Nanoscience & Advanced Materials This segment is dedicated to the research, development, and production of devices and systems for the analysis and application of nanomaterials and structures, as well as for new materials such as polymers, ceramics, and metals. The products included in the program range from atomic force microscopes to analytical electron microscopes and X-ray diffractometers to software for modeling and simulating materials. 4. Bruker Scientific Services This segment offers a variety of services for all the aforementioned attribute areas, providing customers with useful services such as repairs, technical support, and training. In addition, the company also offers maintenance contracts, calibrations, upgrades, and spare parts for its instruments and systems. In summary, Bruker offers a wide portfolio of products and solutions for science and industry. Bruker's business model is focused on providing professional and technologically advanced products and services for research institutions, laboratories, and companies.

What is the Bruker dividend?

Bruker pays a dividend of 0.2 USD distributed over 4 payouts per year.

How often does Bruker pay dividends?

Bruker pays out a dividend 4 times a year.

What is the Bruker ISIN?

The ISIN of Bruker is US1167941087.

What is the Bruker WKN?

The WKN of Bruker is 813534.

What is the Bruker ticker?

The ticker of Bruker is BRKR.

How much dividend does Bruker pay?

Over the past 12 months, Bruker paid a dividend of 0.2 USD . This corresponds to a dividend yield of about 0.3 %. For the coming 12 months, Bruker is expected to pay a dividend of 0.25 USD.

What is the dividend yield of Bruker?

The current dividend yield of Bruker is 0.3 %.

When does Bruker pay dividends?

Bruker pays a quarterly dividend. This is distributed in the months of December, March, July, September.

How secure is the dividend of Bruker?

Bruker paid dividends every year for the past 13 years.

What is the dividend of Bruker?

For the upcoming 12 months, dividends amounting to 0.25 USD are expected. This corresponds to a dividend yield of 0.38 %.

In which sector is Bruker located?

Bruker is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bruker kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bruker from 9/16/2024 amounting to 0.05 USD, you needed to have the stock in your portfolio before the ex-date on 8/30/2024.

When did Bruker pay the last dividend?

The last dividend was paid out on 9/16/2024.

What was the dividend of Bruker in the year 2023?

In the year 2023, Bruker distributed 0.2 USD as dividends.

In which currency does Bruker pay out the dividend?

The dividends of Bruker are distributed in USD.

All fundamentals about Bruker

Our stock analysis for Bruker Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bruker Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.